JNCE logo

Jounce Therapeutics (JNCE) Long Term Liabilities

Annual Total Long Term Liabilities

$5.87 M
-$4.12 M-41.26%

December 31, 2022


Summary


Performance

JNCE Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherJNCEbalance sheetmetrics:

Quarterly Long Term Liabilities

$5.87 M
-$1.06 M-15.25%

December 31, 2022


Summary


Performance

JNCE Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherJNCEbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

JNCE Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-41.3%-41.3%
3 y3 years-65.2%-65.2%
5 y5 years-91.2%-91.2%

JNCE Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-41.3%at low-41.3%at low
5 y5-year-65.2%at low-65.2%at low
alltimeall time-94.6%-76.2%-95.4%-76.2%

Jounce Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Dec 2022
$5.87 M(-41.3%)
$5.87 M(-15.2%)
Sep 2022
-
$6.93 M(-13.2%)
Jun 2022
-
$7.98 M(-11.4%)
Mar 2022
-
$9.01 M(-9.9%)
Dec 2021
$9.99 M(-26.6%)
$9.99 M(-8.5%)
Sep 2021
-
$10.92 M(-7.9%)
Jun 2021
-
$11.86 M(-7.2%)
Mar 2021
-
$12.77 M(-6.2%)
Dec 2020
$13.62 M(-19.4%)
$13.62 M(-5.9%)
Sep 2020
-
$14.47 M(-5.4%)
Jun 2020
-
$15.30 M(-5.1%)
Mar 2020
-
$16.11 M(-4.6%)
Dec 2019
$16.89 M
$16.89 M(-4.3%)
Sep 2019
-
$17.64 M(-23.1%)
DateAnnualQuarterly
Jun 2019
-
$22.95 M(-46.7%)
Mar 2019
-
$43.07 M(-3.8%)
Dec 2018
$44.78 M(-33.2%)
$44.78 M(-26.7%)
Sep 2018
-
$61.07 M(-22.7%)
Jun 2018
-
$78.98 M(-16.8%)
Mar 2018
-
$94.87 M(+41.6%)
Dec 2017
$67.00 M(-38.4%)
$67.00 M(-15.3%)
Sep 2017
-
$79.13 M(-0.9%)
Jun 2017
-
$79.89 M(-14.2%)
Mar 2017
-
$93.11 M(-14.4%)
Dec 2016
$108.77 M(+7685.8%)
$108.77 M(-15.1%)
Sep 2016
-
$128.06 M(+9066.5%)
Dec 2015
$1.40 M(-75.0%)
$1.40 M
Dec 2014
$5.59 M
-

FAQ

  • What is Jounce Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Jounce Therapeutics?
  • What is Jounce Therapeutics annual total long term liabilities year-on-year change?
  • What is Jounce Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Jounce Therapeutics?
  • What is Jounce Therapeutics quarterly long term liabilities year-on-year change?

What is Jounce Therapeutics annual total long term liabilities?

The current annual total long term liabilities of JNCE is $5.87 M

What is the all time high annual total long term liabilities for Jounce Therapeutics?

Jounce Therapeutics all-time high annual total long term liabilities is $108.77 M

What is Jounce Therapeutics annual total long term liabilities year-on-year change?

Over the past year, JNCE annual total long term liabilities has changed by -$4.12 M (-41.26%)

What is Jounce Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of JNCE is $5.87 M

What is the all time high quarterly long term liabilities for Jounce Therapeutics?

Jounce Therapeutics all-time high quarterly total long term liabilities is $128.06 M

What is Jounce Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, JNCE quarterly total long term liabilities has changed by -$4.12 M (-41.26%)